Scientists have long struggled to target proteins that lack defined structure and are involved in cancer, neurodegenerative ...

In diseases like Parkinson's and Alzheimer's ... This new platform integrates computational design and directed evolution to develop new antibodies, which are then screened for their ability ...

During the past decade, Parkinson disease (PD ... In the clinical setting, this evolution is reflected in an increasing demand for mutational analysis of PD-associated genes by doctors and ...

Targets to Therapies Initiative will de-risk drug development to expand foundational knowledge of underexplored drug targets through a multi-year research program Research ...

AI-driven software is 96% accurate at diagnosing Parkinson's. Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of ...

Fox Foundation identified several hundred diverse promising targets for drug development in Parkinson's disease Consortium of Parkinson's scientists, industry researchers and investors narrowed ...